JWH 073 N-(4-hydroxybutyl) metabolite – 5 mg

Brand:
Cayman
CAS:
335161-14-3
Storage:
-20
UN-No:
Non-Hazardous - /

JWH 073 is a mildly selective agonist of the central cannabinoid (CB1) receptor derived from the aminoalkylindole WIN 55,212-2. The Ki values for binding CB1 and the peripheral cannabinoid (CB2) receptor are 8.9 and 38 nM, respectively for a CB1:CB2 ratio of 0.23.{16797} JWH 073 is one of several synthetic CBs which have been included in smoking mixtures. JWH 073 N-(4-hydroxybutyl) metabolite is expected to be a major urinary metabolite of JWH 073, characterized by monohydroxylation of the N-alkyl chain, based on the metabolism of the closely-related JWH 015 and JWH 018.{18292,18291} In urine samples, this metabolite of JWH 018 is almost completely glucuronidated.{18291}  

 

Available on backorder

SKU: 9000865 - 5 mg Category:

Description

Expected to be a major urinary metabolite of JWH 073


Formal name: (1-(4-hydroxybutyl)-1H-indol-3-yl)(naphthalen-1-yl)-methanone

Synonyms: 

Molecular weight: 343.4

CAS: 335161-14-3

Purity: ≥98%

Formulation: A crystalline solid